Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response
NCT00518154
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
7
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Pyridostigmine tablets
Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran